These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18774185)

  • 1. Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'?
    Kato T
    Trends Neurosci; 2008 Oct; 31(10):495-503. PubMed ID: 18774185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mitochondrial dysfunction in bipolar disorder].
    Kato T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Apr; 25(2):61-72. PubMed ID: 16220655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiological trait abnormalities in bipolar disorder.
    Langan C; McDonald C
    Mol Psychiatry; 2009 Sep; 14(9):833-46. PubMed ID: 19455151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobiology of bipolar disorder - lessons from migraine disorders.
    Holland J; Agius M
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S162-5. PubMed ID: 21894127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatoglyphic analysis in Malay subjects with bipolar mood disorder.
    Chakraborty D; Mazumdar P; Than M; Singh R
    Med J Malaysia; 2001 Jun; 56(2):223-6. PubMed ID: 11771083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiology of bipolar disorder.
    Newberg AR; Catapano LA; Zarate CA; Manji HK
    Expert Rev Neurother; 2008 Jan; 8(1):93-110. PubMed ID: 18088203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.
    Kato T
    CNS Drugs; 2007; 21(1):1-11. PubMed ID: 17190525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force.
    Frey BN; Andreazza AC; Houenou J; Jamain S; Goldstein BI; Frye MA; Leboyer M; Berk M; Malhi GS; Lopez-Jaramillo C; Taylor VH; Dodd S; Frangou S; Hall GB; Fernandes BS; Kauer-Sant'Anna M; Yatham LN; Kapczinski F; Young LT
    Aust N Z J Psychiatry; 2013 Apr; 47(4):321-32. PubMed ID: 23411094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?
    Lagace DC; Eisch AJ
    Psychiatr Clin North Am; 2005 Jun; 28(2):399-414. PubMed ID: 15826739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mitochondrial dysfunction in bipolar disorder.
    Kato T
    Drug News Perspect; 2006 Dec; 19(10):597-602. PubMed ID: 17299601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond.
    Kato T
    Schizophr Res; 2017 Sep; 187():62-66. PubMed ID: 27839913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder.
    Kato T
    Cell Calcium; 2008 Jul; 44(1):92-102. PubMed ID: 18177933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions.
    Mazza M; Di Nicola M; Della Marca G; Janiri L; Bria P; Mazza S
    Neuroscientist; 2007 Aug; 13(4):392-404. PubMed ID: 17644769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder.
    Kakiuchi C; Iwamoto K; Ishiwata M; Bundo M; Kasahara T; Kusumi I; Tsujita T; Okazaki Y; Nanko S; Kunugi H; Sasaki T; Kato T
    Nat Genet; 2003 Oct; 35(2):171-5. PubMed ID: 12949534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Hamrin V; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
    Manji HK; Moore GJ; Chen G
    J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter abnormalities as brain structural vulnerability factors for bipolar disorder: A review of neuroimaging studies of individuals at high genetic risk for bipolar disorder.
    Nery FG; Monkul ES; Lafer B
    Aust N Z J Psychiatry; 2013 Dec; 47(12):1124-35. PubMed ID: 23864160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder.
    Kapczinski F; Frey BN; Kauer-Sant'Anna M; Grassi-Oliveira R
    Expert Rev Neurother; 2008 Jul; 8(7):1101-13. PubMed ID: 18590480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.